Metabolism, Uptake, and Transepithelial Transport of the Diastereomers of Val-Val in the Human Intestinal Cell Line, Caco-2
Tóm tắt
Purpose. The purpose of this study was to determine whether the binding of the diastereomers of Val-Val to the apical oligopeptide transporter(s) could be correlated with their cellular uptake and transepithelial transport.
Methods. The Caco-2 cell culture system was used for all experiments. The binding of the diastereomers of Val-Val was evaluated by determining their ability to inhibit [3H]cephalexin uptake. The stability of the diastereomers was determined in a homogenate of Caco-2 cells and in the apical bathing solution over Caco-2 cell monolayers. The cellular uptake and transepithelial transport properties of the individual diastereomers were studied using Caco-2 cell monolayers.
Results. 10 mM concentrations of L-Val-L-Val, L-Val-D-Val, D-Val-L-Val and D-Val-D-Val inhibited cellular uptake of [3H]cephalexin (0.1 mM) by 92%, 37%, 70%, and 18%, respectively. When the cellular uptake of Val-Val diastereomers (1 mM) were evaluated, the intracellular concentrations of L-Val-D-Val and D-Val-L-Val were 15 and 50 times higher, respectively, than that of D-Val-D-Val. The cellular uptake of L-Val-D-Val and D-Val-L-Val was inhibited by Gly-Pro (10 mM) (>95%), whereas Gly-Pro had no effect on the cellular uptake of D-Val-D-Val. L-Val-L-Val was not detected in the Caco-2 cells, probably due to its metabolic lability. When the transepithelial transport of the Val-Val diastereomers (1 mM) was determined, L-Val-D-Val, D-Val-L-Val and D-Val-D-Val transport rates were similar. The transepithelial transport of L-Val-D-Val and D-Val-L-Val was inhibited by Gly-Pro (10 mM) 36% and 30%, respectively, while Gly-Pro inhibited carnosine (1 mM) transepithelial transport by 65%. Gly-Pro had no effect on the transepithelial transport of D-Val-D-Val.
Conclusions. These results suggest that the major transepithelial transport route of L-Val-D-Val, D-Val-L-Val and D-Val-D-Val is passive diffusion via the paracellular route. The binding of Val-Val diastereomers to the oligopeptide transporter(s) is a good predictor of their cellular uptake, however, the binding is not a good predictor of their transepithelial transport. It appears that the stereochemical requirements for the transporter that mediates efflux of the peptide across the basolateral membrane may be different from the requirements for the apical transporter that mediates cellular uptake.
Tài liệu tham khảo
C. H. Gochoco, F. M. Ryan, J. Miller, P. L. Smith, and I. J. Hidalgo. Uptake and transepitherial transport of orally absorbed cephalosporine cephalexin in the human intestinal cell line, Caco-2. Int. J. Pharm. 104:187–202 (1994).
D. M. Matthews and S. A. Adibi. Peptide absorption. Gastroenterology 71:151–161 (1976).
V. Ganapathy and F. H. Leibach. Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249:G153–G160 (1985).
A. H. Dantzig and L. Bergin. Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun. 155:1082–1087 (1988).
I. J. Hidalgo, F. M. Ryan, G. J. Marks, and P. L. Smith. pH-dependent transepithelial transport of cephalexin in rabbit intestinal mucosa. Int. J. Pharm. 98:83–92 (1993).
P. W. Swaan, M. C. Stehouwer, R. I. C. Blok, and J. J. Tukker. Prodrug approach using the intestinal peptide carrier. Pharm. Res. 10:S-295 (1993).
M. Hu, P. Subramanian, H. I. Mosberg, and G. L. Amidon. Use of the peptide carrier system to improve the intestinal absorption of L-α-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-α-methyldopa. Pharm. Res. 6:66–70 (1989).
J. P. F. Bai. pGlu-L-Dopa-Pro: Tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion. Pharm. Res. 12:1101–1104 (1995).
P. L. Smith, E. P. Eddy, C.-P. Lee, and G. Wilson. Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Delivery 1:103–111 (1993).
W. Kramer, F. Girbig, U. Gutjahr, S. Kowalewski, F. Adam, and W. Schiebler. Intestinal absorption of β-lactam antibiotics and oligopeptides. Eur. J. Biochem. 204:923–930 (1992).
K. Miyazaki, K. Iseki, and T. Arita. Intestinal absorption of several β-lactam antibiotics. IV. Binding to the various components in the intestinal mucosa of rat and role in absorption process. J. Pharm. Dyn. 5:593–602 (1982).
F. M. Ryan and P. L. Smith. Effects of altering fluid transport on the absorption of benzylpenicillin and mannitol across rat intestinal mucosa in vitro. Pharm. Res. 6:S88 (1989).
J. Dyer, R. B. Beechey, J.-P. Gorvel, R. T. Smith, R. Wootton, and S. P. Shirazi-Beechey. Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem. J. 269:565–571 (1990).
K.-I. Inui, M. Yamamoto, and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport system in apical and basolateral membrane. J. Pharmacol. Exp. Ther. 261:195–201 (1992).
H. Saito and K.-I. Inui. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am.J. Physiol. 265:G289–G294 (1993).
S.-I. Matumoto, H. Saito, and K.-I. Inui. Transepithelial transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: Interaction with dipeptide transport systems in apical and basolateral membranes. J. Pharmcol. Exp. Ther. 270:498–504 (1994).
D. T. Thwaites, C. D. A. Brown, B. H. Hirst, and N. L. Simmons. Transepithelial Glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H+-coupled carriers at both apical and basal membranes. J. Biol. Chem. 268:7640–7642 (1993).
I. J. Hidalgo, P. Bhatnagar, C.-P. Lee, J. Miller, G. Cucullino, and P. L. Smith. Structural requirments for interaction with the oligopeptide transporter in Caco-2 cells. Pharm. Res. 12:317–319 (1995).
I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736–749 (1989).
D. Wessel and U. I. Flugge. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:141–143 (1984).
P. J. Chikhale and R. T. Borchardt. Metabolism of L-α-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. Drug Metab. Disp. 22:592–600 (1994).
D. M. Matthews, J. M. Addison, and D. Burston. Evidence for active transport of the dipeptide carnosine (βalanyl-L-histidine) by human jejunum in vitro. Clin. Sci. Molec. Med. 46:693–705 (1974).
J. M. Addison, D. M. Matthews, and D. Burston. Competition between carnosine and other peptides for transport by human jejunum in vitro. Clin. Sci. Molec. Med. 46:707–714 (1974).
M. L. G. Gardner, K. M. Illingworth, J. Kelleher, and D. Wood. Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactose. J. Physiol. 439:411–422 (1991).
K. M. Hillgren, P. F. Augustijns, and R. T. Borchardt. Carnosine as a substrate for the peptide carrier in Caco-2 cells. Pharm. Res. 10:S-181 (1993).